Pharma News

16 December 2024

Activating the hidden pharmaceutical potential of bacteria

Researchers develop a new genetic method for the production of new active ingredients in bacteria

16 December 2024

Researchers describe a potential target to address a severe heart disease in diabetic patients

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders. This often under-diagnosed heart function impairment is one of the leading causes of death in diabetic patients and it affects both type 1 and type 2 diabetes. There is no current specific drug treatment or clinical protocol approved to address this disease.

16 December 2024

A low omega-6, omega-3 rich diet and fish oil may slow prostate cancer growth : study finds

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may help reduce cancer cell growth in patients undergoing active surveillance, a treatment approach that involves regular monitoring of the cancer without immediate intervention.

13 December 2024

Lynparza demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase III trial

Updated results from the OlympiA Phase III trial showed AstraZeneca and MSDs Lynparza olaparib demonstrated sustained, clinically meaningful improvements in overall survival , invasive disease-free survival IDFS and distant disease-free survival DDFS at six years for patients with germline BRCA-mutated gBRCAm HER2-negative high-risk early breast cancer.

13 December 2024

IBRANCE® in combination with Standard-of-Care therapies extends survival by over 15 months

Pfizer Inc. and Alliance Foundation Trials, LLC announced results from the Phase 3 PATINA trial demonstrating that the addition of IBRANCE palbociclib to current standard-of-care first-line maintenance therapy following induction chemotherapy resulted in statistically significant and clinically meaningful improvement in progression-free survival by investigator assessment in patients with hormone receptor-positive

13 December 2024

Antidepressants may act in gut to reduce depression and anxiety

Most of us have experienced the effects of moods and emotions on our gastrointestinal tract, from “butterflies” in the stomach caused by nervousness to a loss of appetite when we’re feeling blue.

13 December 2024

A new class of antivirals could help prevent future pandemics

The arrival of Paxlovid in December 2021 marked another turning point in the COVID-19 pandemic—an effective antiviral that has since successfully treated millions. But like many antivirals before it, scientists know that at some point, Paxlovid is likely to lose some efficacy due to drug resistance. Researchers working to stay ahead of such emerging threats have now identified a wholly new way to treat SARS-CoV-2 infections—work that may have even broader implications.

12 December 2024

Cipla receives approval for distribution and marketing of inhaled insulin in India

Cipla Limited announced that it has obtained regulatory approval from Central Drugs Standard Control Organisation for the exclusive distribution and marketing of Afrezza insulin human Inhalation Powder in India. Afrezza, a product created and manufactured by MannKind Corporation

12 December 2024

Identifying a proliferating repairman for tissue in damaged lungs

Veins in the lungs, or pulmonary veins, play a critical role not only in lung functioning but also in maintaining sufficient oxygen in tissue throughout the body. When a person sustains pulmonary injury from an illness like influenza or COVID, repair of blood vessels and the creation of new ones is vital to meet oxygen demands; however, research in these areas remains underexplored.

12 December 2024

Updated Hep B Vaccine More Effective for People with HIV

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to the results of an international study led by a Weill Cornell Medicine investigator.

Search

Activating the hidden pharmaceutical potential of bacteria

RECOMMENDED POSTS

Subscribe with us

Jobs by Category